Open Access. Powered by Scholars. Published by Universities.®
Biomedical Engineering and Bioengineering Commons™
Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Biomedical Engineering and Bioengineering
Modeling And Experimental Methods To Predict Oxygen Distribution In Bone Defects Following Cell Transplantation, Christopher M. Heylman, Sharon Santoso, Melissa D. Krebs, Gerald M. Saidel, Eben Alsberg, George F. Muschler
Modeling And Experimental Methods To Predict Oxygen Distribution In Bone Defects Following Cell Transplantation, Christopher M. Heylman, Sharon Santoso, Melissa D. Krebs, Gerald M. Saidel, Eben Alsberg, George F. Muschler
Biomedical Engineering
We have developed a mathematical model that allows simulation of oxygen distribution in a bone defect as a tool to explore the likely effects of local changes in cell concentration, defect size or geometry, local oxygen delivery with oxygen-generating biomaterials (OGBs), and changes in the rate of oxygen consumption by cells within a defect. Experimental data for the oxygen release rate from an OGB and the oxygen consumption rate of a transplanted cell population are incorporated into the model. With these data, model simulations allow prediction of spatiotemporal oxygen concentration within a given defect and the sensitivity of oxygen tension …
A Strategy For Integrating Essential Three-Dimensional Microphysiological Systems Of Human Organs For Realistic Anticancer Drug Screening, Christopher Heylman, Agua Sobrino, Venktesh S. Shirure, Christopher Cw Hughes, Steven C. George
A Strategy For Integrating Essential Three-Dimensional Microphysiological Systems Of Human Organs For Realistic Anticancer Drug Screening, Christopher Heylman, Agua Sobrino, Venktesh S. Shirure, Christopher Cw Hughes, Steven C. George
Biomedical Engineering
Cancer is one of the leading causes of morbidity and mortality around the world. Despite some success, traditional anticancer drugs developed to reduce tumor growth face important limitations primarily due to undesirable bone marrow and cardiovascular toxicity. Many drugs fail in clinical development after showing promise in preclinical trials, suggesting that the available in vitro and animal models are poor predictors of drug efficacy and toxicity in humans. Thus, novel models that more accurately mimic the biology of human organs are necessary for high-throughput drug screening. Three-dimensional (3D) microphysiological systems can utilize induced pluripotent stem cell technology, tissue engineering, and …